Business Context and Reporting Period
Radiopharm Theranostics Limited filed this Form 6-K as a foreign private issuer for September 2026. It reports that the Company published an ASX announcement on September 30, 2026, titled “Appendix 4G and Corporate Governance Statement.” The announcement is identified as Exhibit 99.1, but its contents are not included in the filing text provided.
Financial Results and Liquidity
The filing text provides no revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics.
Changes, Outlook, and Risks
The filing text does not describe financial or operational changes, guidance, management commentary, risks, contingencies, or unusual items. It is an announcement transmittal, not a results report.
Important Facts to Verify
- Review Exhibit 99.1 for the Appendix 4G and Corporate Governance Statement disclosures.
- Verify any governance compliance statements, exceptions, or explanations in the exhibit; these are not available in the provided filing text.
- The filing states it is not deemed “filed” for Exchange Act purposes and is not incorporated by reference into registration statements or prospectuses unless specifically referenced.